Advertisement ProImmune introduces new protein, peptide microarray platform - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

ProImmune introduces new protein, peptide microarray platform

ProImmune has introduced ProArray Ultra, a protein and peptide array platform, which allows analysis of more than 30,000 peptides or proteins at once, and typically requires only 1ul of analyte sample.

ProArray Ultra, with its sensitivity and flexibility, overcomes the traditional trade-off between optimized 96-well plate-based assays, which are reliable and have good performance characteristics but lack the required throughput, and high throughput array technologies, which are typically only semi-quantitative.

The platform’s applications include antigen and monoclonal antibody characterization, analysis of serum antibody specificity, correlation of antibody responses with disease onset, progression and outcome, protein-protein interaction site mapping, iterative peptide and protein design, and general bioassay design.